Content about Biology

September 26, 2010

Omron Healthcare earlier this month joined forces with “The Dr. Oz Show” in an integrated...

BANNOCKBURN, Ill. —Omron Healthcare earlier this month joined forces with “The Dr. Oz Show” in an integrated media partnership to help spread the word about the importance of home blood pressure monitoring.

September 26, 2010

A study sponsored by Kaz, the manufacturer of Vicks humidifiers, found that such devices as...

LONDON and BOSTON A study sponsored by Kaz, the manufacturer of Vicks humidifiers, found that such devices as humidifiers may play a role in reducing airborne flu viruses in the home.

September 26, 2010

Nutramax Labs recently launched its Samsyl dietary supplement for liver health. Samsyl contains a blend...

EDGEWOOD, Md. —Nutramax Labs recently launched its Samsyl dietary supplement for liver health. Samsyl contains a blend of S-adenosylmethionine, or SAMe, along with a highly bioavailable silybin-soy phosphatidylcholine complex.

September 23, 2010

Several lots of two drugs used to treat anemia are being recalled due to possible...

THOUSAND OAKS, Calif. Several lots of two drugs used to treat anemia are being recalled due to possible contamination.

 

Amgen said Friday that it was voluntarily recalling certain lots of Epogen and Procrit (epoetin alfa) from distributors, wholesalers, healthcare providers and pharmacies as a precaution due to the possible presence of extremely thin and barely visible glass flakes known as lamellae that result from an interaction between the drugs and the glass vials used to store them.

 

 

September 23, 2010

Drug maker Warner Chilcott will buy the U.S. rights to a treatment for overactive bladder...

ARDEE, Ireland Drug maker Warner Chilcott will buy the U.S. rights to a treatment for overactive bladder for $400 million, the company said Friday.

 

The drug maker announced that it would terminate its co-promotion agreement with Novartis concerning the drug Enablex (darifenacin) and purchase the rights to sell it in the United States. It may be required to make additional milestone payments of up to $20 million to Novartis.

 

 

September 21, 2010

A new national survey commissioned by Neutrogena Cosmetics suggested a trend toward a less "made...

LOS ANGELES A new national survey commissioned by Neutrogena Cosmetics suggested a trend toward a less "made up" look for American women. Women expected their cosmetics to deliver flawless skin and sun protection, above fashion-forward colors, according to the findings.

Executed by Harris Interactive, the survey explored the relationship American women have with their cosmetics. It was conducted online within the United States from Aug. 9 to 11, among 1,018 adult women ages 18 years and older.

 

September 20, 2010

Clinere Products on Tuesday announced the launch of its Clinere ear cleaners, with distribution through...

MUNDELEIN, Ill. Clinere Products on Tuesday announced the launch of its Clinere ear cleaners, with distribution through Walmart, Kmart, Walgreens, CVS/pharmacy, Meijer, H-E-B and Shopko.

 

September 20, 2010

Both Wegmans and Supervalu recently announced the availability of flu shots at their respective pharmacies....

September 20, 2010

The Food and Drug Administration has approved a generic treatment for organ transplant patients....

PITTSBURGH The Food and Drug Administration has approved a generic treatment for organ transplant patients.

 

Mylan announced Tuesday the approval of tacrolimus capsules in the 0.5-mg, 1-mg and 5-mg strengths, and said it plans to launch the drug immediately. The drug is used to prevent rejection of transplanted organs.

 

 

September 20, 2010

The Food and Drug Administration is looking for input on regulations concerning knock-off versions of...

WASHINGTON The Food and Drug Administration is looking for input on regulations concerning knock-off versions of biotech drugs, according to published reports.

 

The Hill, a newspaper in Washington, reported Monday that the FDA would have a hearing on Nov. 2 and 3 concerning follow-on biologics, based on a draft document distributed to healthcare lobbyists.

 

 

According to the report, the hearing would focus on such issues as interchangeability and definitions of such terms as “biological product.”

September 20, 2010

Sanofi-Aventis has tapped actors Paul and Mira Sorvino to launch an awareness program aimed to...

BRIDGEWATER, N.J. Sanofi-Aventis has tapped actors Paul and Mira Sorvino to launch an awareness program aimed to help people living with diabetes and those who support them.

 

The "Diabetes Co-Stars" program provides family and friends of diabetics with advice on lifestyle choices, healthy cooking, promoting physical activity and treatment options including insulin, Sanofi-Aventis said. DiabetesCoStars.com provides links to the Sanofi-Aventis diabetes social media pages, including Facebook and Twitter.

 

September 19, 2010

Oragenics, a biopharmaceutical company, has announced that its oral care probiotics line, EvoraPlus, will be...

TAMPA, Fla. Oragenics, a biopharmaceutical company, has announced that its oral care probiotics line, EvoraPlus, will be available at select Fred Meyer stores in September.

"We are pleased that Fred Meyer stores are among the growing number of retailers that have chosen to carry EvoraPlus oral care probiotics," stated Gerry David, EVP sales and marketing for Oragenics. "We are looking forward to the expanded distribution of our oral care probiotics across the northwestern portion of the United States through this relationship."

September 19, 2010

Kmart Pharmacy's more than 900 walk-in flu clinics will be open through Nov. 15 for...

HOFFMAN ESTATES, Ill. — Kmart Pharmacy's more than 900 walk-in flu clinics will be open through Nov. 15 for customers looking to purchase a seasonal flu vaccination.

September 16, 2010

Boehringer Ingelheim has started a late-stage clinical trial of a drug for treating breast cancer,...

INGELHEIM, Germany Boehringer Ingelheim has started a late-stage clinical trial of a drug for treating breast cancer, the German drug maker said Friday.

 

The phase 3 trial, dubbed the “LUX-Breast 1” trial, will evaluate the drug afatinib in patients with advanced breast cancer. The drug is a tablet that BI said was the first to inhibit two chemicals involved in tumor growth -- the epidermal growth factor receptor, or EGFR, and the human epidermal receptor, also known as HER2.

 

 

September 16, 2010

California health officials and healthcare professionals are urging Californians to get vaccinated, as the state...

SACRAMENTO, Calif. California health officials and healthcare professionals are urging Californians to get vaccinated, as the state is on pace for the worst epidemic of pertussis, more commonly known as whooping cough, in more than 50 years. The disease already has claimed the lives of nine infants in the state.

September 16, 2010

Drug-resistant bacterial infections recently have been reported in more than 20 states across the United...

September 16, 2010

Emergent BioSolutions has landed a $51 million contract from the Department of Health and Human...

WASHINGTON Emergent BioSolutions has landed a $51 million contract from the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority to develop a new anthrax vaccine.

In the first two years of the contract, Emergent will develop the final vaccine formulation and test its stability. HHS said it can extend the contract annually for up to three years to support scale-up and optimization for large-scale manufacturing, as well as additional animal studies needed to apply for Food and Drug Administration approval of the vaccine.

September 16, 2010

While the advisory committee vote of 15 opposed and nine in favor of scheduling the...

WHAT IT MEANS AND WHY IT’S IMPORTANT While the advisory committee vote of 15 opposed and nine in favor of scheduling the all-too-common cough-relieving ingredient dextromethorphan as a controlled substance might seem like a healthy indicator as to which direction the Food and Drug Administration will act on this issue, make no mistake: it is by no means a certainty. This still may be an issue for cough-cold season 2011-2012.

September 16, 2010

A new brand of Mediterranean olive oil that features a pop-up pourer has hit store...

ROME, N.Y. A new brand of Mediterranean olive oil that features a pop-up pourer has hit store shelves.

Olivari premium olive oils are ideal for cooking, offering a subtle, fruity aroma and fresh flavor that reflects the authentic Mediterranean diet and provides a perfect substitute for butter, margarine, cooking fats and high-calorie dressings.

 

September 16, 2010

A new study published in Circulation Research, a journal of the American Heart Association, found...

DALLAS A new study published in Circulation Research, a journal of the American Heart Association, found that blood levels of some ribonucleic acids — known as microRNAs — vary among those with Type 2 diabetes or those who develop the disease, compared with healthy people.

 

MicroRNA comprises shorter molecular chains than so-called messenger RNA, which takes the genetic information contained within the DNA and allows it to be turned into proteins with various functions, and previously has been linked to numerous diseases, including diabetes.

September 16, 2010

In response to the outbreak of pertussis, or "whooping cough," in California, one drug store...

September 16, 2010

The heartbreaking news is that California is battling an unnerving whooping cough epidemic that unfortunately...

WHAT IT MEANS AND WHY IT'S IMPORTANT The heartbreaking news is that California is battling an unnerving whooping cough epidemic that unfortunately already has claimed the lives of nine babies. But the silver lining -- if there is one -- lies in the fact that this gives rise to another opportunity for retail pharmacy to demonstrate the critical role it plays in public health crisis management.

(THE NEWS: Calif. health officials address 'whooping cough' outbreak. For the full story, click here)

September 15, 2010

Abbott on Thursday introduced two new nutrition shakes — Ensure Muscle Health and Ensure Clinical...

ABBOTT PARK, Ill. Abbott on Thursday introduced two new nutrition shakes — Ensure Muscle Health and Ensure Clinical Strength — both formulated to help rebuild muscle mass naturally lost with age.

Ensure Muscle Health shakes contain Abbott's proprietary ingredient, Revigor, a source of HMB (beta-hydroxy-beta-methylbutyrate, an amino-acid metabolite), and 13 g of protein.

 

September 14, 2010

A pair of Food and Drug Administration advisory committees on Tuesday evening recommended that the...

WASHINGTON A pair of Food and Drug Administration advisory committees on Tuesday evening recommended that the FDA not place greater sales restrictions on the sale of dextromethorphan by placing the ingredient on the controlled substances schedule. The panel of FDA advisers voted to not schedule DXM by a vote of 15-9.

 

September 14, 2010

The Food and Drug Administration has approved new dosing recommendations for children and adolescents using...

WASHINGTON The Food and Drug Administration has approved new dosing recommendations for children and adolescents using a drug for heart and kidney transplants.

 

The agency announced Wednesday the recommendations, designed to prevent overdosing in children taking Genentech’s antiviral Valcyte (valganciclovir), particularly among those of low weight, smaller size and very low serum creatinine.